Background: Frailty is a syndrome characterised by increase vulnerability to negative outcomes. Interstitial Lung Disease (ILD), asthma, and pleural disease are leading causes of morbidity and mortality. We aimed to investigate the prevalence and impact of frailty in adult patients with these diseases. Methods: We conducted a systematic review and meta-analysis, searching PubMed, Web of Science, The Cochrane Library, and EMBASE for studies reporting on frailty in ILD, asthma, and pleural disease. MeSH terms including Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Non-specific Interstitial Pneumonia, Chronic Hypersensitivity Pneumonitis, Systemic sclerosis-associated ILD, Connective tissue disease-associated ILD, and frailty were used as key words. The primary outcome was prevalence of frailty. Where enough data allowed a pooled random-effects meta-analysis was performed with mortality and hospitalisation as the outcomes. Results: We identified 6 relevant studies incorporating 1471 ILD patients (age 68.3±SD2.38; 50% male), which were either cohort or cross-sectional design rated either good or fair. The median prevalence of frailty was 48% (IQR25-50). There was a positive association between frail ILD patients and increased risk of long-term mortality (pooled OR, 2.33 95%CI 1.31-4.15, I2 9%). One study reported a hospitalization rate of HR=1.97(1.32-3.06) within 6 months in frail ILD patients. We identified 3 studies on frailty in asthma and no studies in pleural disease. The median prevalence in asthma was 9.5% (IQR7.8-11.3). Conclusions: Frailty is very common and associated with increased mortality in patients with ILD. There are still minimal data regarding the prevalence of frailty and its influence on the risk in this population. The review found three studies relating to frailty in asthma, which did not examine its impact on outcomes. No studies relating to pleural disease and frailty were identified.
Frailty prevalence and association with clinical outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease / Verduri, Alessia; Carter, Ben; Rice, Ceara; Laraman, Ames; Barton, Eleanor; Clini, Enrico; Maskell, Nick; Hewitt, Jonathan. - In: GERIATRICS. - ISSN 2308-3417. - 8:4(2023), pp. 1-12. [10.3390/geriatrics8040082]
Frailty prevalence and association with clinical outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease.
Alessia Verduri;Enrico Clini;
2023
Abstract
Background: Frailty is a syndrome characterised by increase vulnerability to negative outcomes. Interstitial Lung Disease (ILD), asthma, and pleural disease are leading causes of morbidity and mortality. We aimed to investigate the prevalence and impact of frailty in adult patients with these diseases. Methods: We conducted a systematic review and meta-analysis, searching PubMed, Web of Science, The Cochrane Library, and EMBASE for studies reporting on frailty in ILD, asthma, and pleural disease. MeSH terms including Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Non-specific Interstitial Pneumonia, Chronic Hypersensitivity Pneumonitis, Systemic sclerosis-associated ILD, Connective tissue disease-associated ILD, and frailty were used as key words. The primary outcome was prevalence of frailty. Where enough data allowed a pooled random-effects meta-analysis was performed with mortality and hospitalisation as the outcomes. Results: We identified 6 relevant studies incorporating 1471 ILD patients (age 68.3±SD2.38; 50% male), which were either cohort or cross-sectional design rated either good or fair. The median prevalence of frailty was 48% (IQR25-50). There was a positive association between frail ILD patients and increased risk of long-term mortality (pooled OR, 2.33 95%CI 1.31-4.15, I2 9%). One study reported a hospitalization rate of HR=1.97(1.32-3.06) within 6 months in frail ILD patients. We identified 3 studies on frailty in asthma and no studies in pleural disease. The median prevalence in asthma was 9.5% (IQR7.8-11.3). Conclusions: Frailty is very common and associated with increased mortality in patients with ILD. There are still minimal data regarding the prevalence of frailty and its influence on the risk in this population. The review found three studies relating to frailty in asthma, which did not examine its impact on outcomes. No studies relating to pleural disease and frailty were identified.File | Dimensione | Formato | |
---|---|---|---|
Verduri (Frailty in ILD, asthma, PDs- review 2023).pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
991.86 kB
Formato
Adobe PDF
|
991.86 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris